Predict your next investment

Corporation

See what CB Insights has to offer

Portfolio Exits

1

About Canaccord Genuity Growth

Canaccord Genuity Growth is a New York-based provider of medical cannabis products and services.

Canaccord Genuity Growth Headquarters Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Canaccord Genuity Growth News

5E Advanced Materials to Participate in the Canaccord Genuity Growth Conference

Aug 11, 2022

08/11/2022 | 06:36am EDT Message : *Required fields HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E,” “We,” “Our,” or the “Company”), a leading boron and lithium company with Critical Infrastructure designation by the U.S. government, today announced that Henri Tausch, President and CEO, and Chance Pipitone, SVP of Corporate Development and Investor Relations, will be presenting at the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022. About 5E Advanced Materials, Inc. 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) is an exploration stage company focused on becoming a vertically integrated global leader and supplier of boron specialty and advanced materials, complemented by lithium production capabilities. Our mission is to become a supplier of these critical materials to industries addressing global decarbonization, food production, and domestic security. We anticipate boron and lithium products will target applications in the fields of electric transportation, clean energy infrastructure such as solar and wind power, fertilizers, and domestic security. Our business strategy and objectives are to develop capabilities ranging from upstream extraction and product sales of boric acid, lithium carbonate and potentially other co-products, to downstream boron advanced material processing and development. Our business is based on our large domestic boron and lithium resource, which is located in Southern California and designated as Critical Infrastructure by the Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency, and we intend to leverage this asset once commercially operational to internally supply our proposed downstream advanced material development activities over time. Authorized for release by: Henri Tausch, President and Chief Executive Officer For further information contact:

Canaccord Genuity Growth Portfolio Exits

1 Portfolio Exit

Canaccord Genuity Growth has 1 portfolio exit. Their latest portfolio exit was Columbia Care on March 23, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/23/2022

Acq - Pending

$99M

3

Date

3/23/2022

Exit

Acq - Pending

Companies

Valuation

$99M

Acquirer

Sources

3

Canaccord Genuity Growth Acquisitions

1 Acquisition

Canaccord Genuity Growth acquired 1 company. Their latest acquisition was Columbia Care on October 18, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/18/2018

Other

$99M

$3.7M

Reverse Merger

4

Date

10/18/2018

Investment Stage

Other

Companies

Valuation

$99M

Total Funding

$3.7M

Note

Reverse Merger

Sources

4

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.